LepVax

N/A

Report date: 2025/03/13 09:30:30

Base Information

Drug NameLepVax
Drug Alias NameLEP-F1/GLA-SEProtein subunit vaccine (leprosy, Infectious Disease Research Institute)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLeprosy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazil
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInfectious Disease Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesInfectious Disease Research InstituteThe Immunobiological Technology Institute
Inactive CompaniesAccess to Advanced Health Institute
Active IndicationsLeprosy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A